Fluorodeoxyglucose (FDG) positron emission tomography combined with computed tomography (PET/CT) has become indispensable in the management of haematological malignancies. By visualising and ...

Expert Rev Anticancer Ther. 2009;9(1):75-96. Based on the available data, FDG-PET alone appears to be of limited use in differentiating tumors of low malignant potential from benign tumors and ovarian ...

Multiple antigen stimulating cellular therapy (MASCT)-I for metastatic urothelial carcinoma (mUC): A multicenter, phase I study (MASCT-I-1001). This is an ASCO Meeting Abstract from the 2023 ASCO ...

For patients with head and neck squamous cell carcinoma, utilizing fluorodeoxyglucose-(FDG)-PET/CT imaging to assess their response to chemoradiation significantly increases the accuracy in ...

The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research presented today at the 38th Annual Congress of the European Association of ...

An analysis of published studies has found that FDG-PET is less effective at diagnosing lung cancer compared to other kinds of benign lung diseases in geographic areas where those diseases are more ...

Correctly distinguishing between related neurodegenerative diseases remains challenging for clinicians, because reliable markers do not yet exist for many disorders. In the July 22 Neurology, ...

Academic Medical Centers and ASCO Recommendations: Starting a Difficult Discussion Table 1. Summary of the Recommendation of the EANM-SNMMI, NCCN, ESMO, and ABC Considering Imaging Modalities to be ...

A first-in-class peptide-based PET tracer, 18 F-AlF-NOTA-PCP2, can effectively measure PD-L1 expression in patients with head and neck cancers, outperforming the conventional tracer 18 F-FDG. 18 F-AlF ...

At the San Antonio Breast Cancer Symposium, Jennifer Specht, MD, of the University of Washington and Fred Hutch Cancer Center, Seattle, presented results from the ECOG-ACRIN FEATURE trial, a phase II ...